Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Gains from Investment Securities (2021 - 2025)

Verrica Pharmaceuticals has reported Gains from Investment Securities over the past 5 years, most recently at $106000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $106000.0 for Q4 2025, down 71.66% from a year ago — trailing twelve months through Dec 2025 was $383000.0 (down 58.55% YoY), and the annual figure for FY2025 was $383000.0, down 58.55%.
  • Gains from Investment Securities for Q4 2025 was $106000.0 at Verrica Pharmaceuticals, up from $94000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for VRCA hit a ceiling of $374000.0 in Q4 2024 and a floor of $1000.0 in Q2 2021.
  • Median Gains from Investment Securities over the past 5 years was $85000.0 (2025), compared with a mean of $89266.7.
  • Biggest five-year swings in Gains from Investment Securities: surged 1526.09% in 2024 and later tumbled 71.66% in 2025.
  • Verrica Pharmaceuticals' Gains from Investment Securities stood at $2000.0 in 2021, then changed by 0.0% to $2000.0 in 2022, then skyrocketed by 1050.0% to $23000.0 in 2023, then surged by 1526.09% to $374000.0 in 2024, then tumbled by 71.66% to $106000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $106000.0 (Q4 2025), $94000.0 (Q3 2025), and $85000.0 (Q2 2025) per Business Quant data.